Artigo em revista científica Q1
Assessing executive dysfunction in neurodegenerative disorders: a critical review of brief neuropsychological tools
Helena S. Moreira (Moreira, H. S.); Ana S. Costa (Costa, A. S.); São Luís Castro (Castro, S. L.); César Lima (Lima, C. F.); Selene G. Vicente ( Vicente, S. G.);
Título Revista
Frontiers in Aging Neuroscience
Ano (publicação definitiva)
2017
Língua
Inglês
País
Suíça
Mais Informação
Web of Science®

N.º de citações: 36

(Última verificação: 2024-04-25 12:08)

Ver o registo na Web of Science®


: 1.1
Scopus

N.º de citações: 32

(Última verificação: 2024-04-23 03:44)

Ver o registo na Scopus


: 1.0
Google Scholar

N.º de citações: 47

(Última verificação: 2024-04-23 03:25)

Ver o registo no Google Scholar

Abstract/Resumo
Executive function (EF) has been defined as a multifaceted construct that involves a variety of high-level cognitive abilities such as planning, working memory, mental flexibility, and inhibition. Being able to identify deficits in EF is important for the diagnosis and monitoring of several neurodegenerative disorders, and thus their assessment is a topic of much debate. In particular, there has been a growing interest in the development of neuropsychological screening tools that can potentially provide a reliable quick measure of EF. In this review, we critically discuss the four screening tools of EF currently available in the literature: Executive Interview-25 (EXIT 25), Frontal Assessment Battery (FAB), INECO Frontal Screening (IFS), and FRONTIER Executive Screen (FES). We first describe their features, and then evaluate their psychometric properties, the existing evidence on their neural correlates, and the empirical work that has been conducted in clinical populations. We conclude that the four screening tools generally present appropriate psychometric properties, and are sensitive to impairments in EF in several neurodegenerative conditions. However, more research will be needed mostly with respect to normative data and neural correlates, and to determine the extent to which these tools add specific information to the one provided by global cognition screening tests. More research directly comparing the available tools with each other will also be important to establish in which conditions each of them can be most useful.
Agradecimentos/Acknowledgements
--
Palavras-chave
Aging,Cognitive impairment,Executive functions,Neuropsychological assessment,Neurodegenerative disorders,Neuropsychological screening,Psychometric properties,Review
  • Medicina Básica - Ciências Médicas
  • Medicina Clínica - Ciências Médicas
Registos de financiamentos
Referência de financiamento Entidade Financiadora
POCI-01-0145-FEDER-0072 COMPETE 2020
IF/00172/2015 Fundação para a Ciência e a Tecnologia
NORTE-01-0145-FEDER-00026 COMPETE 2020
SFRH/BD/105201/2014 Fundação para a Ciência e a Tecnologia
UID/PSI/00050/2013 Fundação para a Ciência e a Tecnologia